Company intelligence
MannKind Corporation
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life. Please visit mannkindcorp.com to learn more.
Verified activity
Signals from MannKind Corporation
3 published signals
Presence & Recognition
MannKind Corporation was named a Connecticut Top Workplace for the third consecutive year.
Reported by MannKind Corporation
Presence & Recognition
MannKind Corporation is participating in the Cantor Global Healthcare Conference in New York, with CEO Michael Castagna and CFO Chris Prentiss joining investors and industry leaders for a fireside chat on September 10 at 11:30 AM ET.
Reported by MannKind Corporation
Presence & Recognition
MannKind Corporation participated in Pulmonary Fibrosis Awareness Month to raise awareness of pulmonary fibrosis.
Reported by MannKind Corporation